BRUSSELS (Reuters) – The European Medicines Agency will hold a news conference at 1300 GMT on Tuesday, a spokesman for the EU’s executive arm said.
EMA is conducting an investigation into the safety of AstraZeneca’s COVID-19 shot after Germany, France, Italy and other EU countries suspended the use of the vaccine over isolated cases of bleeding, blood clots and low platelet counts.
(Reporting by Gabriela Baczynska, Marine Strauss)
